• DOI:10.1182/BLOOD-2016-02-702464
• Corpus ID: 42531420

MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

@article{Choi2016MicroRNA1395pRP,
  title={MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.},
  author={Jinwook Choi and Young‐Kook Kim and Kyungsoo Park and J J Nah and Sung-Soo Yoon and Dong-Wook Kim and V. Narry Kim and Rho Hyun Seong},
  journal={Blood},
  year={2016},
  volume={128 17},
  pages={
          2117-2129
        }
}

• Jinwook Choi, Young‐Kook Kim, +5 authors R. Seong
• Published 27 October 2016
• Biology
• Blood

MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and progenitor cells and that downregulation of miR-139-5p expression was associated with hematopoietic malignancy, such as chronic myeloid leukemia (CML). Knockdown of miR-139-5p resulted in myeloid-biased differentiation with expansion of myeloid progenitor cells. In contrast, miR-139-5p expression inhibited the proliferation of hematopoietic progenitors and resulted in the remission of a CML-like disease that is induced by breakpoint cluster region-Abelson (BCR-ABL) transformation. We also found that Brg1 is a functional target of miR-139-5p and that Brg1 is involved in BCR-ABL-induced leukemogenesis. Thus, our results identify miR-139-5p as a key regulator of cellular proliferation during early hematopoiesis and suggest that it is a potent antileukemic molecule.